Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 09:05 am Purchase | 2025-12-31 | 13G | uniQure N.V. QURE | Avoro Capital Advisors LLC | 6,150,000 9.870% | 2,525,000 (+69.66%) | Filing History |
| 2026-02-17 09:04 am Purchase | 2025-12-31 | 13G | Centessa Pharmaceuticals plc CNTA | Avoro Capital Advisors LLC | 14,555,555 9.970% | 3,747,475 (+34.67%) | Filing History |
| 2026-02-17 09:03 am Sale | 2025-12-31 | 13G | Avidity Biosciences, Inc. RNA | Avoro Capital Advisors LLC | 8,515,792 5.540% | -1,420,000 (-14.29%) | Filing History |
| 2026-02-17 09:02 am Purchase | 2025-12-31 | 13G | Celcuity Inc. CELC | Avoro Capital Advisors LLC | 3,111,111 6.720% | 3,111,111 (New Position) | Filing History |
| 2026-02-17 09:01 am Purchase | 2025-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | Avoro Capital Advisors LLC | 2,900,000 5.400% | 850,000 (+41.46%) | Filing History |
| 2026-02-17 09:00 am Purchase | 2025-12-31 | 13G | Mind Medicine (MindMed) Inc. MNMD | Avoro Capital Advisors LLC | 5,000,000 5.080% | 5,000,000 (New Position) | Filing History |
| 2025-11-14 09:07 am Sale | 2025-09-30 | 13G | Monte Rosa Therapeutics, Inc. GLUE | Avoro Capital Advisors LLC | 0 0.000% | -3,725,000 (Position Closed) | Filing History |
| 2025-11-14 09:06 am Sale | 2025-09-30 | 13G | Amicus Therapeutics, Inc. FOLD | Avoro Capital Advisors LLC | 15,025,000 4.870% | -5,475,000 (-26.71%) | Filing History |
| 2025-11-14 09:05 am Purchase | 2025-09-30 | 13G | Centessa Pharmaceuticals plc CNTA | Avoro Capital Advisors LLC | 10,808,080 8.060% | 10,808,080 (New Position) | Filing History |
| 2025-11-14 09:03 am Sale | 2025-09-30 | 13G | MoonLake Immunotherapeutics MLTX | Avoro Capital Advisors LLC | 2,000,000 3.150% | -2,150,000 (-51.81%) | Filing History |
| 2025-11-14 09:01 am Purchase | 2025-09-30 | 13G | Structure Therapeutics Inc. GPCR | Avoro Capital Advisors LLC | 16,216,665 9.380% | 16,216,665 (New Position) | Filing History |
| 2025-08-14 07:18 am Sale | 2025-06-30 | 13G | Blueprint Medicines Corporation BPMC | Avoro Capital Advisors LLC | 375,000 0.600% | -3,475,000 (-90.26%) | Filing History |
| 2025-08-14 07:13 am Sale | 2025-06-30 | 13G | Soleno Therapeutics, Inc. SLNO | Avoro Capital Advisors LLC | 2,050,000 4.100% | -131,000 (-6.01%) | Filing History |
| 2025-08-14 07:10 am Sale | 2025-06-30 | 13G | Monte Rosa Therapeutics, Inc. GLUE | Avoro Capital Advisors LLC | 3,725,000 6.100% | -620,000 (-14.27%) | Filing History |
| 2025-08-14 07:07 am Sale | 2025-06-30 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR | Avoro Capital Advisors LLC | 11,517,441 8.300% | -511,111 (-4.25%) | Filing History |
| 2025-08-14 07:04 am Purchase | 2025-06-30 | 13G | Tourmaline Bio, Inc. TRML | Avoro Capital Advisors LLC | 2,555,555 9.950% | 333,333 (+15.00%) | Filing History |
| 2025-08-14 06:59 am Purchase | 2025-06-30 | 13G | uniQure N.V. QURE | Avoro Capital Advisors LLC | 3,625,000 6.600% | 3,625,000 (New Position) | Filing History |
| 2025-08-14 06:57 am Purchase | 2025-06-30 | 13G | MoonLake Immunotherapeutics MLTX | Avoro Capital Advisors LLC | 4,150,000 6.500% | 4,150,000 (New Position) | Filing History |
| 2025-05-15 09:31 am Sale | 2025-03-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | Avoro Capital Advisors LLC | 8,700,000 4.200% | -4,350,000 (-33.33%) | Filing History |
| 2025-05-15 09:30 am Sale | 2025-03-31 | 13G | Amicus Therapeutics, Inc. FOLD | Avoro Capital Advisors LLC | 20,500,000 6.700% | -2,675,000 (-11.54%) | Filing History |